Today: 15 May 2026
Dow drops 406 points as oil spike stirs rate worries

Dow drops 406 points as oil spike stirs rate worries

New York, May 15, 2026, 16:01 EDT

  • The Dow Jones Industrial Average fell 406.40 points, down 0.81%, to close at 49,657.06.
  • The S&P 500 and Nasdaq edged lower. Oil prices climbed, and Treasury yields moved up.
  • Traders pulled back their bets on rate cuts. Prediction markets now give strong odds that the Fed won’t cut rates at all in 2026.

Dow Jones Industrial Average fell 406.40 points Friday, sliding back under 50,000 as oil prices and higher bond yields weighed on stocks. The S&P 500 gave up 50.23 points to end at 7,451.01. Nasdaq Composite finished down 195.89 points at 26,439.34.

Stocks turned after the Dow closed above 50,000 for the first time since February and both the S&P 500 and Nasdaq hit new record closes. The AI rally and strong earnings hit resistance as energy prices climbed, yields moved up, and the Fed’s path looked less supportive.

Oil was in focus early. Brent crude closed around $109 a barrel, AP reported. The 10-year Treasury yield hit roughly 4.59%. Stocks often feel pressure when yields go up, since that bumps up borrowing costs and can pull investors from equities with better returns on bonds.

Kenny Polcari, chief market strategist at Slatestone Wealth, told Reuters, “There’s a realization that the market had gotten way ahead of itself.” He said too many investors chased the AI trade and ignored bonds and economic data. Reuters

The Dow underperformed during a broader selloff, as losses hit nearly all parts of the market. Ten out of 11 S&P 500 sectors fell, with only energy in the green. The Philadelphia Semiconductor Index slid 2.3%. Nvidia dropped 2%, AMD slid 3.1% and Intel lost 5.1%, according to Reuters.

The Dow skews to bigger share prices because it’s price-weighted and tracks 30 major U.S. firms, so costly stocks move the index more. S&P 500 and Nasdaq cover more of the market, but both slipped as well.

Rates pulled on the market again. Traders in the CME FedWatch now see a 49.5% chance the Fed hikes rates by at least 25 basis points in December, up from 14.3% last week, according to Reuters. A basis point equals one-hundredth of a percentage point.

Prediction markets didn’t budge. Traders on Polymarket gave zero Fed rate cuts in 2026 a 67% chance, while a 2026 hike held 32%. Over on Kalshi’s interest-rate page, odds of no cuts came in at 68% and one cut got 17%. That market had about $3.7 million in volume.

Fed officials aren’t supporting a steeper rate path. New York Fed President John Williams said Thursday that policy is in a “good place” and he doesn’t see a need to move rates, up or down, at this point. The Middle East war is still keeping price pressures uncertain. Reuters

Oil and yields could keep tightening conditions ahead of any move from the Fed. If the Strait of Hormuz stays disrupted, inflation expectations may stay high and push investors out of expensive stocks. A fast drop in crude would challenge that trade and could help the Dow in after-hours trading for next week.

Stock Market Today

  • GSR V Acquisition Closes $230M IPO on Nasdaq with Full Over-Allotment
    May 15, 2026, 5:35 PM EDT. GSR V Acquisition Corp (NASDAQ:GSRV) completed its initial public offering (IPO), raising $230 million by selling 23 million units at $10 each. The IPO included the full exercise of the underwriter's over-allotment option, indicating strong investor demand. Units, comprising shares and fractional rights convertible into Class A shares post-business combination, began trading on the Nasdaq Global Market under the symbol GSRVU on May 14, 2026. Shares and rights are expected to trade separately under the ticker symbols GSRV and GSRVR respectively. The company's Form S-1 registration, filed under SEC number 333-295415, became effective on May 13, 2026. Market participants will monitor potential business combination updates that could impact share value.

Latest articles

Tonix Pharmaceuticals Stock Jumps as Lyme Disease Antibody Data Put 2027 Trial in Focus

Tonix Pharmaceuticals Stock Jumps as Lyme Disease Antibody Data Put 2027 Trial in Focus

15 May 2026
Tonix Pharmaceuticals filed new Phase 1 modeling data showing its experimental Lyme disease antibody, TNX-4800, could maintain serum levels above a proposed protective threshold for six months with a two-dose regimen. Shares rose $1.65 to $15.74 Friday. The company plans a Phase 2 trial in 2027, pending FDA agreement. No Lyme vaccine is currently available in the U.S.
AXT Stock’s AI Rally Hits Governance Snag as Annual Meeting Is Pushed to June

AXT Stock’s AI Rally Hits Governance Snag as Annual Meeting Is Pushed to June

15 May 2026
AXT adjourned its 2026 annual meeting after failing to reach a quorum, rescheduling for June 4. The company seeks shareholder approval to raise authorized common shares to 120 million from 70 million. Shares closed at $123.78, up 7.65%, after a volatile session. China’s export controls on indium phosphide remain a key risk for AXT’s business.
Hyperscale Data Climbs on $5 Million Tender Offer; Spotlight Turns to 10-Q

Hyperscale Data Climbs on $5 Million Tender Offer; Spotlight Turns to 10-Q

15 May 2026
Hyperscale Data plans a tender offer to buy up to $5 million of Class A shares at $0.21 each, above the last GPUS trade at $0.146. The company reported a preliminary first-quarter net loss of about $30 million on revenue of $44 million and filed a late notice for its Form 10-Q. The offer is pending board and regulatory approval.
Dow slides 406 points as the AI surge stalls and an oil shock rattles the US market
Previous Story

Dow slides 406 points as the AI surge stalls and an oil shock rattles the US market

P3 Health Partners stock jumps as Q1 turns profitable and 2026 outlook is raised
Next Story

P3 Health Partners stock jumps as Q1 turns profitable and 2026 outlook is raised

Go toTop